Measles & Rubella Weekly Monitoring Report – Week 8: February 18 to February 24, 2024
Organization: Public Health Agency of Canada
Date published: 2024-03-07
Related Topics
- Measles and Rubella Weekly Monitoring Reports
- Measles
- Rubella
Key points:
- In Canada, 1 new case of measles and 1 new case of congenital rubella infection were reported in week 8, 2024.
- Currently, there are 7 activeFootnote 1 cases of measles and 2 active cases of congenital rubella syndrome/infection in Canada.
- 7 cases of measles and 1 case of congenital rubella syndrome/infection have been reported in Canada in 2024.
- Canadians travelling outside of Canada are encouraged to consult the travel health notices for information on measles and rubella outbreaks occurring in other countries.
On this page
Epidemiological summary
During epidemiological week 8, 2024, 1 new case of measles and 1 new case of congenital rubella infection were reported in CanadaFootnote 2. The measles case was reported by the province of Ontario and is an unvaccinated child who acquired the infection while travelling outside of Canada. Rash onset occurred in epidemiological week 8.
The congenital rubella infection case was reported by the province of Quebec and is a newborn whose mother had confirmed rubella during their pregnancy. The mother's infection was reported in September 2023 and had acquired the rubella infection outside of Canada.
To date in 2024, 7 cases of measles and 1 case of congenital rubella syndrome/infection have been reported. The last case of rubella was reported in September 2023. The last case of congenital rubella syndrome/infection was reported in August 2023.
![Figure 1. Text version below.](/content/dam/phac-aspc/images/services/publications/diseases-conditions/measles-rubella-surveillance/2024/week-8/fig1-en.jpg)
Figure 1 - Text description
Epidemiological Week of Rash Onset, 2024 | Number of confirmed measles cases reported | Number of confirmed rubella cases reported | Number of confirmed congenital rubella syndrome/infection cases reported |
---|---|---|---|
1 | 0 | 0 | 0 |
2 | 1 | 0 | 0 |
3 | 1 | 0 | 0 |
4 | 0 | 0 | 0 |
5 | 1 | 0 | 0 |
6 | 1 | 0 | 1 |
7 | 2 | 0 | 0 |
8 | 1 | 0 | 0 |
9 | 0 | 0 | 0 |
10 | 0 | 0 | 0 |
11 | 0 | 0 | 0 |
12 | 0 | 0 | 0 |
13 | 0 | 0 | 0 |
14 | 0 | 0 | 0 |
15 | 0 | 0 | 0 |
16 | 0 | 0 | 0 |
17 | 0 | 0 | 0 |
18 | 0 | 0 | 0 |
19 | 0 | 0 | 0 |
20 | 0 | 0 | 0 |
21 | 0 | 0 | 0 |
22 | 0 | 0 | 0 |
23 | 0 | 0 | 0 |
24 | 0 | 0 | 0 |
25 | 0 | 0 | 0 |
26 | 0 | 0 | 0 |
27 | 0 | 0 | 0 |
28 | 0 | 0 | 0 |
29 | 0 | 0 | 0 |
30 | 0 | 0 | 0 |
31 | 0 | 0 | 0 |
32 | 0 | 0 | 0 |
33 | 0 | 0 | 0 |
34 | 0 | 0 | 0 |
35 | 0 | 0 | 0 |
36 | 0 | 0 | 0 |
37 | 0 | 0 | 0 |
38 | 0 | 0 | 0 |
39 | 0 | 0 | 0 |
40 | 0 | 0 | 0 |
41 | 0 | 0 | 0 |
42 | 0 | 0 | 0 |
43 | 0 | 0 | 0 |
44 | 0 | 0 | 0 |
45 | 0 | 0 | 0 |
46 | 0 | 0 | 0 |
47 | 0 | 0 | 0 |
48 | 0 | 0 | 0 |
49 | 0 | 0 | 0 |
50 | 0 | 0 | 0 |
51 | 0 | 0 | 0 |
52 | 0 | 0 | 0 |
Cases (year-to-date) | 7 | 0 | 1 |
Geographic distribution
There are currently 7 activeFootnote * cases of measles and 2 activeFootnote ** cases of congenital rubella syndrome/infection in Canada.
![Figure 2. Text version below.](/content/dam/phac-aspc/images/services/publications/diseases-conditions/measles-rubella-surveillance/2024/week-8/fig2-en.jpg)
Figure 2 - Text description
Health Region | Measles Active Cases |
Eastern Regional Integrated Health Authority | 0 |
Central Regional Integrated Health Authority | 0 |
Western Regional Integrated Health Authority | 0 |
Labrador-Grenfell Regional Integrated Health Authority | 0 |
Prince Edward Island | 0 |
South Shore District Health Authority | 0 |
South West Nova District Health Authority | 0 |
Annapolis Valley District Health Authority | 0 |
Colchester East Hants Health Authority | 0 |
Cumberland Health Authority | 0 |
Pictou County Health Authority | 0 |
Guysborough Antigonish Strait Health Authority | 0 |
Cape Breton District Health Authority | 0 |
Capital District Health Authority | 0 |
Zone 1 (NB) | 0 |
Zone 2 (NB) | 0 |
Zone 3 (NB) | 0 |
Zone 4 (NB) | 0 |
Zone 5 (NB) | 0 |
Zone 6 (NB) | 0 |
Zone 7 (NB) | 0 |
Québec et Chaudières-Appalaches | 0 |
Centre-du-Québec | 0 |
Montréal et Laval | 2 |
Ouest-du-Québec | 0 |
Montérégie | 0 |
Nord-Est | 0 |
Ontario Central East | 1 |
Ontario Central West | 1 |
Ontario Eastern | 0 |
Ontario North East | 0 |
Ontario North West | 0 |
Ontario South West | 1 |
City of Toronto Health Unit | 1 |
Winnipeg Regional Health Authority | 0 |
Prairie Mountain Health | 0 |
Interlake-Eastern Regional Health Authority | 0 |
Northern Regional Health Authority | 0 |
Southern Health | 0 |
Saskatchewan South | 0 |
Saskatchewan Central | 1 |
Saskatchewan North | 0 |
South Zone | 0 |
Calgary Zone | 0 |
Central Zone | 0 |
Edmonton Zone | 0 |
North Zone | 0 |
British Columbia | 0 |
Yukon | 0 |
Northwest Territories | 0 |
Nunavut | 0 |
![Figure 3. Text version below.](/content/dam/phac-aspc/images/services/publications/diseases-conditions/measles-rubella-surveillance/2024/week-8/fig3-en.jpg)
Figure 3 - Text description
Health Region | Measles Active Cases |
Eastern Regional Integrated Health Authority | 0 |
Central Regional Integrated Health Authority | 0 |
Western Regional Integrated Health Authority | 0 |
Labrador-Grenfell Regional Integrated Health Authority | 0 |
Prince Edward Island | 0 |
South Shore District Health Authority | 0 |
South West Nova District Health Authority | 0 |
Annapolis Valley District Health Authority | 0 |
Colchester East Hants Health Authority | 0 |
Cumberland Health Authority | 0 |
Pictou County Health Authority | 0 |
Guysborough Antigonish Strait Health Authority | 0 |
Cape Breton District Health Authority | 0 |
Capital District Health Authority | 0 |
Zone 1 (NB) | 0 |
Zone 2 (NB) | 0 |
Zone 3 (NB) | 0 |
Zone 4 (NB) | 0 |
Zone 5 (NB) | 0 |
Zone 6 (NB) | 0 |
Zone 7 (NB) | 0 |
Québec et Chaudières-Appalaches | 1 |
Centre-du-Québec | 0 |
Montréal et Laval | 0 |
Ouest-du-Québec | 0 |
Montérégie | 0 |
Nord-Est | 0 |
Ontario Central East | 0 |
Ontario Central West | 1 |
Ontario Eastern | 0 |
Ontario North East | 0 |
Ontario North West | 0 |
Ontario South West | 0 |
City of Toronto Health Unit | 0 |
Winnipeg Regional Health Authority | 0 |
Prairie Mountain Health | 0 |
Interlake-Eastern Regional Health Authority | 0 |
Northern Regional Health Authority | 0 |
Southern Health | 0 |
Saskatchewan South | 0 |
Saskatchewan Central | 0 |
Saskatchewan North | 0 |
South Zone | 0 |
Calgary Zone | 0 |
Central Zone | 0 |
Edmonton Zone | 0 |
North Zone | 0 |
British Columbia | 0 |
Yukon | 0 |
Northwest Territories | 0 |
Nunavut | 0 |
- Footnote *
-
Active measles cases are those in which the onset date of the case falls within 42 days of the end date of the epidemiological week of the reportFootnote 4. Active rubella cases are those in which the onset date of the case falls within 46 days of the end date of the epidemiological week of the reportFootnote 5.
- Footnote **
-
Infants with CRS are considered infectious until they are at least 1 year old or until 2 clinical specimens obtained 1 month apart are negative for rubella virus by RT-PCR, either real-time or conventional; culture is also acceptable.
Laboratory summary
Measles
During epidemiological week 8, 2024, the measles genotype was identified for 3 cases that were reported in epidemiological weeks 4 and 6: two cases reported by the province of Ontario and one case reported by the province of Quebec. All cases had international travel. Genotype D8 was detected in one case and genotype B3 in two cases, one of which was identical to the WHO named strain MVs/Quetta.PAK/44.20.
To date in 2024, 4 cases of measles have been genotyped and the genotypes were B3 (n=2) and D8 (n=2).
![Figure 4. Text version below.](/content/dam/phac-aspc/images/services/publications/diseases-conditions/measles-rubella-surveillance/2024/week-8/fig4-en.jpg)
Figure 4 - Text description
Epi week | B3 | B3 - Harare | D4 | D8 | D8 – Taunton | D9 | H1 | Total |
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
5 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
6 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
37 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
38 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
44 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
48 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
51 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 4 |
- Footnote †
-
Epidemiological weeks for laboratory specimens submitted to the National Microbiology Laboratory are assigned and reported in accordance with WHO guidelines (WHO.WER.2012;9(87):73) with week 1 beginning on the first Monday of the year, which for 2024 is January 1. However, for the purposes of this report, the genotype data is presented in accordance with PAHO reporting weeks with week 1 of 2024 beginning on December 31, 2023.
For information regarding the interpretation and use of measles genotyping (including a discussion of genotypes and named strains), refer to Hiebert J and Severini A. Canada Communicable Disease Report. 2014; 40-12: 257- 260.
The current global distribution of measles genotypes can be found on the WHO Measles Surveillance website.
Footnotes
- Footnote 1
-
Active measles cases are those in which the onset date of the case falls within 42 days of the end date of the epidemiological week of the report. Active rubella cases are those in which the onset date of the case falls within 46 days of the end date of the epidemiological week of the report.
- Footnote 2
-
Only cases with rash onset up to the indicated end date are included in this report. Any additional cases will be described in future reports.
- Footnote 3
-
Epidemiological week of birth is used for congenital rubella syndrome/infection cases.
- Footnote 4
-
The Centers for Disease Control and Prevention. Manual for the Surveillance of Vaccine-Preventable Diseases. Chapter 7: Measles. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt07-measles.html. Page last reviewed: May 13, 2019.
- Footnote 5
-
The Centers for Disease Control and Prevention. Manual for the Surveillance of Vaccine-Preventable Diseases. Chapter 14: Rubella. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt14-rubella.html. Page last reviewed: May 18, 2018.
- Footnote 6
-
The active congenital rubella syndrome case in Ontario (Central West) was initially reported in Saskatchewan.
Page details
- Date modified: